Dr. Hadley Jean Sharp, MD

Dr. Sharp practices at Atrium Health University City in Charlotte, North Carolina, part of Advocate Health.

Dr. Sharp's NPI, 1497926604, was assigned on March 14, 2008. Dr. Sharp graduated from University of Nebraska College of Medicine in 2007. Dr. Sharp holds North Carolina license 2012-00052.

Dr. Sharp's primary practice is Atrium Health University City, at 8800 North Tyron Street, Charlotte, NC 28262 in Mecklenburg County. The practice phone is (704) 548-6000.

Dr. Sharp's primary practice is Atrium Health University City in Charlotte, North Carolina, part of Advocate Health. Dr. Sharp is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is SERO (Southeast Radiation Oncology Group). Dmand AI also links Dr. Sharp to 3 more group practices and clinics, 2 medical groups and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharp practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Sharp's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Sharp's licenses on file in 3 states: North Carolina, Colorado and South Carolina.

CMS data shows 1,415 Medicare services from Dr. Sharp across 17 procedure codes in 2024, for 104 Medicare patients. Medicare paid $104,558 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 104 Medicare patients who saw Dr. Sharp in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have cancer, and 72% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sharp's median patient age at 72, with 47% women.

In 2024, Dr. Sharp wrote 124 Medicare Part D claims for 69 patients. 83% of them were for generic drugs. CMS names the drug for 84 of them, across 4 drugs with 11 or more claims each, at $1,146 in total drug cost. In 2023, CMS named 70 claims across 3 drugs.

Dr. Sharp accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sharp as offering telehealth.

Dmand AI links 13 papers to Dr. Sharp, published from 2010 to 2023. 2011 was the busiest year, with 3. The most frequent topics are Adenocarcinoma. Dr. Sharp's most frequent co-authors are Hiral P. Fontanilla, MD, Chelsea C. Pinnix, MD, PhD and Laurence D. Rhines, MD.

Dmand AI links Dr. Sharp to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 7 general payments to Dr. Sharp from 5 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. Elekta, Inc. paid the most, $142.

Dr. Sharp graduated from University of Nebraska College of Medicine in 2007.